Indication
Chorioretinal Vascular Disease
1 clinical trial
2 products
Product
ABP 938Product
AfliberceptClinical trial
An Open Label, Two-Arm Study in Subjects With Chorioretinal Vascular Disease to Evaluate ABP 938 and Aflibercept (Eylea®) in a Prefilled SyringeStatus: Completed, Estimated PCD: 2023-02-17